Covered recipient · General Payments record
CRISTIAN CONSTANTINESCU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$6,015.24
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $840.00 | 1 |
| Food and Beverage | $730.29 | 35 |
| Education | $101.49 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $1,089.62 | 12 |
| Amgen Inc. | $160.79 | 4 |
| Teva Pharmaceuticals USA, Inc. | $150.56 | 5 |
| UCB, Inc. | $93.12 | 6 |
| ABBVIE INC. | $74.22 | 4 |
| Biogen, Inc. | $51.77 | 3 |
| CSL Behring | $20.00 | 1 |
| Vanda Pharmaceuticals Inc. | $16.63 | 1 |
| Celgene Corporation | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.74 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103498158 | CMS |
| ABBVIE INC. | $18.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103498160 | CMS |
| ABBVIE INC. | $18.54 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103498162 | CMS |
| ABBVIE INC. | $18.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103498164 | CMS |
| Amgen Inc. | $14.59 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553504 | CMS |
| Amgen Inc. | $123.59 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553506 | CMS |
| Amgen Inc. | $14.07 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553508 | CMS |
| Amgen Inc. | $8.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553510 | CMS |
| Biogen, Inc. | $15.93 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104830206 | CMS |
| Biogen, Inc. | $17.93 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847642 | CMS |
| Biogen, Inc. | $17.91 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104862592 | CMS |
| Celgene Corporation | $15.07 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101178104 | CMS |
| CSL Behring | $20.00 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134663805 | CMS |
| EMD Serono, Inc. | $13.47 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120211806 | CMS |
| EMD Serono, Inc. | $31.32 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120241945 | CMS |
| EMD Serono, Inc. | $8.89 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120211808 | CMS |
| EMD Serono, Inc. | $11.25 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120241947 | CMS |
| EMD Serono, Inc. | $10.47 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120251928 | CMS |
| EMD Serono, Inc. | $12.15 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217634 | CMS |
| EMD Serono, Inc. | $8.33 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217822 | CMS |
| EMD Serono, Inc. | $8.71 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217268 | CMS |
| EMD Serono, Inc. | $8.22 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120269076 | CMS |
| EMD Serono, Inc. | $124.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120278556 | CMS |
| EMD Serono, Inc. | $11.82 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120269088 | CMS |
| EMD Serono, Inc. | $840.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120280406 | CMS |
| Teva Pharmaceuticals USA, Inc. | $1.60 | 02/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151529819 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.74 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151529821 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.62 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151529871 | CMS |
| Teva Pharmaceuticals USA, Inc. | $101.49 | 04/27/2024 | Education | Undisputed | 01/23/2026 | 1151529903 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.11 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151529883 | CMS |
| UCB, Inc. | $15.72 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090136 | CMS |
| UCB, Inc. | $16.73 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090138 | CMS |
| UCB, Inc. | $18.38 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090140 | CMS |
| UCB, Inc. | $14.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090142 | CMS |
| UCB, Inc. | $13.26 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090144 | CMS |
| UCB, Inc. | $14.81 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143090146 | CMS |
| Vanda Pharmaceuticals Inc. | $16.63 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133900067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.